…
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Clover Corporation is an Australian specialty ingredient company that produces medium-chain triglyceride (MCT) oils and other specialty lipids for food, beverage and nutraceutical applications. Long-term growth drivers include rising consumer demand for ketogenic and functional nutrition, expanding global markets for specialty lipids, and product differentiation in higher-margin ingredient categories. The company may benefit from exposure to health-focused ingredient trends and established manufacturing capabilities.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-07-31 | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-07-31 | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
| Income before tax | 15.50M | 10.44M | 1.86M | 8.36M | 9.84M |
| Net income | 10.46M | 7.01M | 1.51M | 6.21M | 7.13M |
| Selling general administrative | - | 7.61M | 5.56M | 5.51M | 4.56M |
| Selling and marketing expenses | - | 5.58M | 4.82M | 5.69M | 4.00M |
| Gross profit | 33.97M | 26.17M | 16.86M | 23.74M | 21.53M |
| Reconciled depreciation | - | 1.56M | 1.17M | 0.92M | 0.71M |
| Ebit | 16.35M | 10.68M | 2.82M | 9.09M | 10.29M |
| Ebitda | 17.78M | 12.24M | 3.98M | 10.01M | 11.01M |
| Depreciation and amortization | 1.43M | 1.56M | 1.17M | 0.92M | 0.71M |
| Operating income | 16.35M | 8.33M | 3.07M | 9.09M | 10.29M |
| Other operating expenses | 81.06M | 77.67M | 59.03M | 71.51M | 60.26M |
| Interest expense | 0.04M | 0.24M | 0.90M | 0.73M | 0.46M |
| Tax provision | - | 3.42M | 0.40M | 2.16M | 2.71M |
| Interest income | - | 0.54M | 1.21M | 1.22M | 1.11M |
| Net interest income | - | -0.24M | -0.90M | -0.73M | -0.46M |
| Income tax expense | 5.05M | 3.42M | 0.40M | 2.16M | 2.71M |
| Total revenue | 97.41M | 86.00M | 62.21M | 79.88M | 70.66M |
| Total operating expenses | 17.62M | 17.84M | 14.90M | 15.37M | 11.13M |
| Cost of revenue | 63.44M | 59.83M | 45.34M | 56.14M | 49.13M |
| Total other income expense net | -0.84M | 2.10M | -1.21M | -0.19M | -0.46M |
| Net income from continuing ops | - | 7.01M | 1.51M | 6.21M | 7.13M |
| Net income applicable to common shares | - | 7.01M | 1.51M | 6.21M | 7.13M |
| Breakdown | 2026-07-31 | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-07-31 | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
| Total assets | 97.76M | 86.80M | 84.39M | 86.20M | 90.60M |
| Other current assets | 1.53M | - | - | 1.74M | 1.22M |
| Total liab | 19.80M | 14.57M | 17.32M | 19.05M | 27.56M |
| Total stockholder equity | 77.96M | 72.23M | 67.07M | 67.15M | 63.04M |
| Other current liab | 8.42M | - | - | 2.20M | 6.43M |
| Common stock | 36.27M | - | - | 36.27M | 35.60M |
| Capital stock | - | 36.27M | 36.27M | 36.27M | 35.60M |
| Retained earnings | 43.11M | 35.88M | 32.00M | 31.74M | 28.45M |
| Other liab | - | - | - | 1.18M | 0.02M |
| Good will | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M |
| Other assets | - | - | - | 1.29M | 0.84M |
| Cash | 7.22M | 8.68M | 12.26M | 9.44M | 10.11M |
| Total current liabilities | 18.75M | 12.68M | 9.83M | 8.29M | 17.25M |
| Net debt | -6.15M | - | - | 2.27M | 1.97M |
| Short term debt | 0.40M | - | - | 2.13M | 1.78M |
| Short long term debt | - | 0.92M | 3.44M | 1.74M | 1.67M |
| Short long term debt total | 1.07M | - | - | 11.71M | 12.08M |
| Other stockholder equity | - | - | - | -0.19M | -1.01M |
| Property plant equipment | - | - | - | 11.34M | 9.18M |
| Total current assets | 69.96M | 59.03M | 56.88M | 60.01M | 66.86M |
| Long term investments | - | 11.33M | 11.25M | 11.66M | 11.82M |
| Net tangible assets | - | - | - | 65.24M | 61.13M |
| Net receivables | 17.27M | 23.47M | 12.00M | 11.95M | 19.56M |
| Long term debt | - | - | 5.03M | 7.69M | 9.24M |
| Inventory | 43.95M | 24.14M | 29.55M | 36.88M | 35.97M |
| Accounts payable | 9.93M | 6.12M | 5.08M | 3.96M | 9.04M |
| Accumulated other comprehensive income | -1.42M | - | - | -0.85M | -1.01M |
| Non current assets total | 27.80M | 27.77M | 27.51M | 26.20M | 23.74M |
| Capital lease obligations | - | 1.50M | 1.92M | 2.28M | 1.17M |
| Long term debt total | - | - | - | 9.58M | 10.30M |
| Breakdown | 2026-07-31 | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-07-31 | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
| Investments | - | -1.34M | -2.97M | -2.53M | -1.60M |
| Change to liabilities | - | - | - | -8.69M | 0.07M |
| Total cashflows from investing activities | -0.46M | -1.34M | -2.97M | -2.53M | -1.60M |
| Net borrowings | - | -7.57M | -5.97M | -1.96M | -2.30M |
| Total cash from financing activities | -5.40M | -10.52M | -2.66M | -4.88M | -3.96M |
| Change to operating activities | - | - | - | 1.48M | 1.97M |
| Net income | 10.46M | 7.01M | 1.51M | 6.21M | 7.13M |
| Change in cash | -1.47M | -3.58M | 2.82M | -0.67M | 1.02M |
| Begin period cash flow | 8.68M | 12.26M | 9.44M | 10.11M | 9.09M |
| End period cash flow | 7.22M | 8.68M | 12.26M | 9.44M | 10.11M |
| Total cash from operating activities | 4.39M | 8.29M | 8.45M | 6.74M | 7.84M |
| Depreciation | 1.43M | - | 1.17M | 0.81M | 0.71M |
| Other cashflows from investing activities | - | 0.00M | -0.36M | -0.89M | -0.89M |
| Dividends paid | 3.34M | -2.50M | -1.25M | -2.92M | -1.66M |
| Change to inventory | -19.81M | 5.41M | 7.32M | -0.91M | -5.19M |
| Change to account receivables | 6.71M | -11.40M | -1.76M | 7.61M | -6.30M |
| Sale purchase of stock | -0.70M | - | - | - | - |
| Other cashflows from financing activities | -0.44M | -0.45M | 4.56M | -0.23M | -0.13M |
| Change to netincome | - | - | - | 0.19M | 0.41M |
| Capital expenditures | 1.07M | 1.34M | 2.33M | 1.64M | 1.60M |
| Change in working capital | -9.20M | 0.50M | 5.80M | -0.73M | -0.46M |
| Stock based compensation | - | - | 0.04M | - | - |
| Other non cash items | 1.70M | 7.78M | -0.07M | - | -7.84M |
| Free cash flow | 3.32M | 6.95M | 6.13M | -1.64M | 6.25M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CLV Clover Corporation Ltd |
-0.02 1.93% |
1.01 | 17.25 | 26.18 | 1.77 | 2.14 | 1.65 | 9.48 |
| A2M The a2 Milk Company Ltd |
-0.13 1.79% |
7.13 | 29.04 | 28.74 | 2.68 | 5.94 | 2.85 | 17.82 |
| BGA Bega Cheese Ltd |
0.02 0.31% |
6.43 | 35.61 | 22.94 | 0.52 | 1.93 | 0.60 | 11.82 |
| CBO Cobram Estate Olives Ltd |
- -% |
2.70 | - | - | 4.79 | 2.48 | 6.63 | 185.44 |
| RIC Ridley Corporation Ltd |
- -% |
2.68 | 38.29 | 13.42 | 0.35 | 2.01 | 0.53 | 4.50 |
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.
39 Pinnacle Road, Altona North, VIC, Australia, 3025
61 3 8347 5000
81
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter J. Davey GAICD, gradDip Bus., MBA | CEO, MD & Exec. Director | NA |
| Mr. Andrew G. M. Allibon C.A. | CFO & Company Sec. | NA |
| Mr. David Pierotti | Operations Mang. | NA |
| Mr. Timothy Murphy | Human Resource & Payroll Mang. | NA |
| S. Poothong | Chief Commercial Officer | NA |
| Mr. Peter J. Davey GAICD, gradDip Bus., MBA | CEO, MD & Executive Director | NA |
| Mr. Andrew G. M. Allibon C.A. | CFO & Company Secretary | NA |
| Mr. David Pierotti | Director of Operations | NA |
| Mr. Bassam Hallak | Director of Sales & Marketing | NA |
| Ms. Anne Roach | General Manager of People & Culture | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.